Effect of skin coverage method following subcuticular suturing on wound infection rates at cesarean delivery.

Objective: The objective of this study was to determine whether the use of cyanoacrylate skin glue following subcuticular skin closure was associated with a decrease in wound outcomes in comparison with subcuticular closure plus Steri-strips at cesarean delivery.

Methods: This was a retrospective cohort study of patients undergoing cesarean delivery at a single center over a two-year period. The primary outcome of wound infection and secondary outcomes of wound separation and composite wound complication rate were assessed throughout the six-week postpartum period.

Treatment of a late second-trimester incarcerated uterus using ultrasound-guided manual reduction.

Background: Incarcerated gravid uterus diagnosed after 20 weeks of gestation is extremely rare and carries significant morbidity to the fetus and mother.

Case: A 33-year-old woman presented at 21 weeks of gestation with urinary retention. Ultrasonography was performed and a diagnosis of an incarcerated gravid uterus was confirmed using magnetic resonance imaging.

Spontaneous methicillin-resistant Staphylococcus aureus epidural abscess in pregnancy.

Background: Epidural abscess is a rare complication of regional anesthesia, and spontaneous formation is even more uncommon. Diabetes mellitus, concomitant infection, intravenous drug use, and immune suppression are risk factors for spontaneous epidural abscess.

Case: A 29-year-old white woman presented at 28 weeks of estimated gestational age reporting an intermittent headache.

Spontaneous severe ovarian hyperstimulation syndrome in successive pregnancies with successful outcomes.

Background: Ovarian hyperstimulation syndrome is a known complication of ovarian stimulation, particularly with injectable gonadotropins. Spontaneous ovarian hyperstimulation is rare and often involves a conformational change in the follicle-stimulating hormone receptor, increasing its binding with human chorionic gonadotropin or thyroid-stimulating hormone. Few data are available regarding the management or outcomes of spontaneous ovarian hyperstimulation syndrome.